Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2273 - 2280 of 11454 results
The Road Less Travelled: Why Arbitration is an Increasingly Attractive Alternative for Resolving IP Disputes
September 26, 2021| Blog| Viewpoint
What We’re Reading – September 24, 2021
September 24, 2021| Blog| Viewpoint
Industry’s Touting Of Citizen Suit Standing Hurdles Appears ‘Optimistic’
September 24, 2021| News
Patent Owner Tip #18 for Surviving an Instituted IPR: Defending Depositions
September 23, 2021| Blog| Viewpoint
OIG Report Highlights Importance of Telehealth in Providing Behavioral Health Services, but Emphasizes Need for Additional Oversight
September 23, 2021| Blog| Viewpoint
California’s New Privacy Regulator Invites You to Comment
September 23, 2021| Blog| Viewpoint
EXCLUSIVE RIGHTS: Intellectual Property — Blockchain, Cryptocurrency, and IP: What Does the Future Hold?
September 23, 2021| Podcast| Viewpoint
The Impact of the ACA Employer Shared Responsibility Rules and Wellness Program Limits on COVID-19 Premium Surcharges
September 23, 2021| Blog| Viewpoint
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz IP Group Named “Litigation Department of the Year” in 2024 New England Legal Awards
October 02, 2024
Mintz’s intellectual property litigation group was named “Litigation Department of the Year” for the IP specialty category in the 2024 New England Legal Awards. The awards recognize attorneys and firms in Connecticut, Maine, Vermont, New Hampshire, Massachusetts, and Rhode Island.
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.